Geron (GERN) Says First Patient Treated in Embryonic Stem Cell Study

October 11, 2010 10:03 AM EDT Send to a Friend
Shares of Geron Corporation (Nasdaq: GERN) are higher this morning after announcing enrollment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login